Clemson University Research Foundation Announces Launch of Newest High Impact Company Tiger Bioanalytics
Tiger Bioanalytics commercializes advanced genetic technology
CLEMSON, SC – July 9, 2012: The Clemson University Research Foundation is proud to announce the launch of Tiger Bioanalytics, aimed at commercializing innovative genetic sensing technology emerging from Clemson University research.
Tiger Bioanalytics, led by Dr. Guigen Zhang of Clemson University, is developing a cost-effective way to more accurately conduct gene sequencing. The goal is to sequence a whole genome using DNA from a single cell in a short period of time with high accuracy at a low cost. Tiger Bioanalytics’s technology promises a more accurate and affordable approach.
“The new technology that we are developing aims to provide a better way to discriminate nucleotides in a solid-state device such that rapid, affordable and accurate genomic sequencing can be done routinely to improve our health and quality of life. Our technology will not only impact the genomic market but also benefit biomedical research as well as global-health initiatives” states Dr. Zhang.
The background research has been supported by $100,000 research funding from the Bill and Melinda Gates Foundation, and more recently, Tiger Bioanalytics received $25K in seed money from SC Launch. Dr. Zhang is currently seeking additional capital and additional partners with expertise in genetic technology commercialization.
Clemson University Research Foundation
The Clemson University Research Foundation (CURF) is a non-profit corporation that facilitates the transfer of Clemson University’s intellectual property to the private sector for commercial development and societal benefit. To learn more about CURF services and to view current technologies available for license, visit www.clemson.edu/curf
Tiger Bioanalytics, Ltd. Co. is a startup company dedicated to the development and commercialization of novel bioanalytic tools such as nanopore DNA sequencers and other biosensors along with companion services for advancing personalized medicine, cancer screening, disease diagnosis, drug development, as well as for improving animal welfare and agricultural and food products, and even environmental protection. Tiger Bioanalytics, Ltd. Co. is a Clemson University spinoff company located in Pendleton, South Carolina. For more information, visit www.tigerbioanalytics.com